Insider trades
Vivo Opportunity, 10% Owner of InMed Pharmaceuticals INM, has filed 19 purchases and 29 sales on the open market. Over the past 12 months that comes to a net purchase of $391.6K. The latest trade was on 06/08.
Vivo Opportunity
10% Owner
- Company
- InMed Pharmaceuticals INM
- First filing
- 23/08/10
- Trades
- 53 trades
- Buys / sales
- 19 / 29
- 12-month net buying
- $391.6K
- Last trade
- 06/08
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
INM | Open-market buy | 05/20–06/08 | 06/10 | 249,227 sh18 trades | $1.57avg. | $391,554.51 | No record |
| Open-market sale | 25/03/26–25/03/28 | 25/03/28 | 1,833,557 sh3 trades | $67.87avg. | $124,449,124.2 | −29.1% | |
| Open-market sale | 24/08/27–24/08/29 | 24/08/29 | 1,025,000 sh3 trades | $48.01avg. | $49,210,750 | −14.0% | |
| Open-market sale | 24/04/29–24/04/30 | 24/05/01 | 1,101,242 sh2 trades | $46.95avg. | $51,701,551.46 | −13.1% | |
| Open-market sale10b5-1 plan | 24/04/01–24/04/03 | 24/04/03 | 420,663 sh9 trades | $6.65avg. | $2,796,859.03 | −61.0% | |
BOLT | Open-market sale | 23/11/21 | 23/11/22 | 3,400 sh3 trades | $0.90avg. | $3,060 | −3.0% |
BOLT | Open-market sale | 23/11/16–23/11/20 | 23/11/20 | 86,054 sh9 trades | $0.93avg. | $79,933.22 | −43.2% |
IO BiotechIOBTQ | Open-market buy | 23/08/09 | 23/08/10 | 3,157,894 sh | $1.90 | $5,999,998.6 | No record |
